Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | serotonin transporter | 0.0109 | 0.5 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0109 | 0.5 | 0.5 |
Echinococcus granulosus | serotonin transporter | 0.0109 | 0.5 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0109 | 0.5 | 0.5 |
Loa Loa (eye worm) | serotonin transporter b | 0.0109 | 0.5 | 0.5 |
Loa Loa (eye worm) | norepinephrine transporter | 0.0109 | 0.5 | 0.5 |
Treponema pallidum | sodium- and chloride- dependent transporter | 0.0109 | 0.5 | 0.5 |
Onchocerca volvulus | 0.0109 | 0.5 | 0.5 | |
Loa Loa (eye worm) | hypothetical protein | 0.0109 | 0.5 | 0.5 |
Schistosoma mansoni | sodium/chloride dependent transporter | 0.0109 | 0.5 | 0.5 |
Loa Loa (eye worm) | solute carrier family 6 member 4 | 0.0109 | 0.5 | 0.5 |
Schistosoma mansoni | norepinephrine/norepinephrine transporter | 0.0109 | 0.5 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Ki (functional) | = 160 nM | Inhibition of Dopamine reuptake from rat caudate using [3H]-DA | ChEMBL. | 11689080 |
Ki (binding) | = 270 nM | Binding affinity against Dopamine transporter using [125]RTI-55 | ChEMBL. | 11689080 |
Ki (binding) | = 630 nM | Binding affinity against Muscarinic receptor from rat brain membranes using [3H]-Pirenzepine | ChEMBL. | 11689080 |
Ki (functional) | = 7100 nM | Inhibition of 5-HT reuptake from rat caudate using [3H]-5-HT | ChEMBL. | 11689080 |
Ki (binding) | = 30 uM | Binding affinity against serotonin transporter using [125]RTI-55 | ChEMBL. | 11689080 |
Ratio (binding) | = 44 | Ratio of inhibition of reuptake of Dopamine to that of serotonin transporter | ChEMBL. | 11689080 |
Ratio (binding) | = 111 | Ratio of binding affinity against Dopamine to that of serotonin transporter | ChEMBL. | 11689080 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.